Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
Diabet Med. 2020 Jan;37(1):114-122. doi: 10.1111/dme.14173. Epub 2019 Nov 19.
To examine the relative association between fasting plasma glucose vs post-load (1-h and 2-h) glucose levels based on the oral glucose tolerance test in pregnancy and large-for-gestational-age and hypertensive disorders of pregnancy outcomes.
All live singleton births between October 2008 and December 2014 in Alberta, Canada were included. Gestational diabetes mellitus was diagnosed using Diabetes Canada criteria. Logistic regression models were used to examine the association between fasting plasma glucose vs post-load values and large-for-gestational-age infants and hypertensive disorders of pregnancy after adjusting for maternal characteristics and pharmaceutical intervention in gestational diabetes pregnancies.
Among 257 547 pregnancies, 208 344 (80.9%) had negative 50-g glucose challenge tests, 36 261 (14.1%) had negative 75-g oral glucose tolerance tests, and 12 942 (5.0%) had gestational diabetes based on either elevated fasting plasma glucose (n=4130, 1.6%) or elevated 1-h and/or 2-h oral glucose tolerance test values (n=8812, 3.4%). Large-for-gestational-age and hypertensive disorders of pregnancy rates were 8.1% and 5.1% in negative glucose challenge test pregnancies, 11.0% and 7.0% in negative oral glucose tolerance test pregnancies, 22.4% and 11.9% in gestational diabetes pregnancies with elevated fasting plasma glucose, and 9.1% and 8% in gestational diabetes pregnancies with elevated post-load levels, respectively. Among gestational diabetes pregnancies, those with elevated fasting plasma glucose were at higher risk of large-for-gestational age (adjusted odds ratio 2.66, 95% CI 2.39-2.96) and hypertensive disorders of pregnancy (adjusted odds ratio 1.51, 95% CI 1.33-1.72) outcomes relative to pregnancies with post-load glucose elevations only. Fasting plasma glucose remained significantly associated with adverse outcomes in gestational diabetes pregnancies with and without pharmacological intervention.
Elevated fasting plasma glucose in women with gestational diabetes is a stronger predictor of large-for-gestational-age and hypertensive disorders of pregnancy outcomes than elevated post-load glucose.
根据口服葡萄糖耐量试验(OGTT),研究妊娠期间空腹血糖与负荷后(1 小时和 2 小时)血糖水平与巨大儿和妊娠高血压疾病结局之间的相对关联。
纳入 2008 年 10 月至 2014 年 12 月期间加拿大艾伯塔省所有单胎活产。妊娠期糖尿病采用加拿大糖尿病协会标准诊断。采用 logistic 回归模型,在校正母亲特征和妊娠期糖尿病药物干预后,分析空腹血糖与负荷后值与巨大儿和妊娠高血压疾病之间的关联。
在 257547 例妊娠中,208344 例(80.9%)50g 葡萄糖筛查试验阴性,36261 例(14.1%)75g OGTT 阴性,12942 例(5.0%)根据空腹血糖升高(n=4130,1.6%)或 1 小时和/或 2 小时 OGTT 值升高(n=8812,3.4%)诊断为妊娠期糖尿病。50g 葡萄糖筛查试验阴性妊娠的巨大儿和妊娠高血压疾病发生率分别为 8.1%和 5.1%,75g OGTT 阴性妊娠分别为 11.0%和 7.0%,空腹血糖升高的妊娠期糖尿病妊娠分别为 22.4%和 11.9%,负荷后血糖升高的妊娠期糖尿病妊娠分别为 9.1%和 8.0%。在妊娠期糖尿病妊娠中,与负荷后血糖升高的妊娠相比,空腹血糖升高的妊娠发生巨大儿(调整比值比 2.66,95%CI 2.39-2.96)和妊娠高血压疾病(调整比值比 1.51,95%CI 1.33-1.72)的风险更高。在有和没有药物干预的妊娠期糖尿病妊娠中,空腹血糖仍然与不良结局显著相关。
与负荷后血糖升高相比,妊娠期糖尿病妇女空腹血糖升高是巨大儿和妊娠高血压疾病结局的更强预测因素。